Data gathered: May 17
Alternative Data for RxSight
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 32 | Sign up | Sign up | Sign up |
| Sentiment | 88 | Sign up | Sign up | Sign up |
| Webpage traffic | 16,000 | Sign up | Sign up | Sign up |
| Employee Rating | 63 | Sign up | Sign up | Sign up |
| Google Trends | 6 | Sign up | Sign up | Sign up |
| Patents | 24 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 57 | Sign up | Sign up | Sign up |
| Facebook Followers | 501 | Sign up | Sign up | Sign up |
| Instagram Followers | 1,598 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 216 | Sign up | Sign up | Sign up |
| Twitter Followers | 197 | Sign up | Sign up | Sign up |
| Twitter Mentions | 30 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 493 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 43 | Sign up | Sign up | Sign up |
| Linkedin Employees | 303 | Sign up | Sign up | Sign up |
About RxSight
RxSight, Inc., an ophthalmic medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally.
| Price | $62.26 |
| Target Price | Sign up |
| Volume | 310,500 |
| Market Cap | $2.24B |
| Year Range | $20.91 - $64.29 |
| Dividend Yield | 0% |
| Revenue per Employee | $333,986 |
| Industry | Medical Devices |
In the news
 |
Analysts Set RxSight, Inc. (NASDAQ:RXST) Target Price at $60.63May 16 - ETF Daily News |
 |
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional SharesMay 13 - Marketscreener.com |
 |
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesMay 13 - Yahoo |
RxSight, Inc. (NASDAQ:RXST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$72.75May 10 - Yahoo Entertainment |
|
 |
RxSight First Quarter 2024 Earnings: Beats ExpectationsMay 9 - Yahoo Entertainment |
|
RxSight (NASDAQ:RXST) PT Raised to $72.00May 9 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '24 | 30M | 32M | 21M | -9.1M | -7.9M | -0.250 |
| Q4 '23 | 29M | 32M | 18M | -9.2M | -9.8M | -0.260 |
| Q3 '23 | 21M | 28M | 14M | -12M | -13M | -0.310 |
| Q2 '23 | 19M | 27M | 12M | -14M | -11M | -0.390 |
| Q1 '23 | 16M | 23M | 10M | -13M | -12M | -0.420 |
Insider Transactions View All
| Kurtz Ronald M MD filed to sell 764,610 shares at $60.1. May 6 '24 |
| Thunen Shelley B filed to sell 13,938 shares at $53. May 2 '24 |
| Thunen Shelley B filed to sell 14,318 shares at $52.7. May 2 '24 |
| Thunen Shelley B filed to sell 8,945 shares at $50.4. April 2 '24 |
| Thunen Shelley B filed to sell 8,402 shares at $51.5. April 2 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$74.55 0% | 64 |
 |
Edwards LifesciencesEW |
$90.11 0% | 58 |
 |
Intuitive SurgicalISRG |
$396.43 0% | 59 |
 |
MedtronicMDT |
$85.64 0% | 56 |
 |
StrykerSYK |
$334.1 0% | 59 |
Read more about RxSight (RXST) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of RxSight?
The Market Cap of RxSight is $2.24B.
How Many People Work at RxSight?
As of our latest update, RxSight employed approximately 292 people worldwide. However, it's important to note that RxSight's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.
What is RxSight's revenue per employee?
$333,986. To calculate RxSight's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.
What is the current stock price of RxSight?
Currently, the price of one share of RxSight stock is $62.26.
How can I analyze the RXST stock price chart for investment decisions?
The RXST stock price chart above provides a comprehensive visual representation of RxSight's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling RxSight shares. Our platform offers an up-to-date RXST stock price chart, along with technical data analysis and alternative data insights.
Does RXST offer dividends to its shareholders?
As of our latest update, RxSight (RXST) does not offer dividends to its shareholders. Investors interested in RxSight should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of RxSight?
Some of the similar stocks of RxSight are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.